Pennsylvania HB2646 amends insurance policies to ensure they do not exclude or restrict coverage for prescription drugs approved by the FDA for.

Pennsylvania HB2646 amends the Insurance Company Law of 1921 to ensure that clinical review criteria for medical policies do not exclude or restrict coverage for prescription drugs approved by the FDA for serious or life-threatening conditions. This change applies to insurers and managed care plans, ensuring that patients have access to necessary medications without arbitrary exclusions based on FDA approval status. The act takes effect 60 days after enactment.

Pennsylvania HB2646 amends insurance policies to ensure they do not exclude or restrict coverage for prescription drugs approved by the FDA for.

Pennsylvania HB2646 amends the Insurance Company Law of 1921 to ensure that clinical review criteria for medical policies do not exclude or restrict coverage for prescription drugs approved by the FDA for serious or life-threatening conditions. This change applies to insurers and managed care plans, ensuring that patients have access to necessary medications without arbitrary exclusions based on FDA approval status. The act takes effect 60 days after enactment.